OOIR: Observatory of International Research

Papers

(The TQCC of BMJ Open Diabetes Research & Care is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Prevalence, incidence and mortality of type 1 and type 2 diabetes in Denmark 1996–2016	128
Novel subgroups of type 2 diabetes and their association with microvascular outcomes in an Asian Indian population: a data-driven cluster analysis: the INSPIRED study	114
Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study	106
Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic	102
Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation	80
Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus	63
Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial	59
Comparison of the effects of lockdown due to COVID-19 on glucose patterns among children, adolescents, and adults with type 1 diabetes: CGM study	58
Urinary metals and incident diabetes in midlife women: Study of Women’s Health Across the Nation (SWAN)	57
Glycemic variability and cardiovascular disease in patients with type 2 diabetes	57
Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes	53
Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing	51
Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-label controlled trial	51
Artificial intelligence-enabled screening for diabetic retinopathy: a real-world, multicenter and prospective study	50
Hypoglycemia in patient with type 2 diabetes treated with insulin: it can happen	50
Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 inhibitors versus GLP-1 receptor agonists in real-life	48
Impact and efficacy of mobile health intervention in the management of diabetes and hypertension: a systematic review and meta-analysis	48
Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis	48
Association between metformin and neurodegenerative diseases of observational studies: systematic review and meta-analysis	47
Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation	46
Insulin sensitivity predicts cognitive decline in individuals with prediabetes	45
Adverse outcomes in COVID-19 and diabetes: a retrospective cohort study from three London teaching hospitals	44
Impact of undiagnosed type 2 diabetes and pre-diabetes on severity and mortality for SARS-CoV-2 infection	43
Diabetes mellitus is associated with a higher risk for major depressive disorder in women than in men	43
Long-term trends in the prescription of antidiabetic drugs: real-world evidence from the Diabetes Registry Tyrol 2012–2018	43

Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study	42
Clinical characterization of data-driven diabetes subgroups in Mexicans using a reproducible machine learning approach	42
Prevalence of peripheral neuropathy in pre-diabetes: a systematic review	37
Association between race/ethnicity and the risk of amputation of lower extremities among medicare beneficiaries with diabetic foot ulcers and diabetic foot infections	37
‘Going the distance’: an independent cohort study of engagement and dropout among the first 100 000 referrals into a large-scale diabetes prevention program	37
Survival and factors predicting mortality after major and minor lower-extremity amputations among patients with diabetes: a population-based study using health information systems	37
Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK	37
Validation of a type 1 diabetes algorithm using electronic medical records and administrative healthcare data to study the population incidence and prevalence of type 1 diabetes in Ontario, Canada	36
Quantifying the underestimation of projected global diabetes prevalence by the International Diabetes Federation (IDF) Diabetes Atlas	36
Circulating long non-coding RNAs NKILA, NEAT1, MALAT1, and MIAT expression and their association in type 2 diabetes mellitus	34
Prediction of diabetic kidney disease with machine learning algorithms, upon the initial diagnosis of type 2 diabetes mellitus	34
Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9	33
Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis	33
Incidence and risk factors for mortality and end-stage renal disease in people with type 2 diabetes and diabetic kidney disease: a population-based cohort study in the UK	33
Uptake and impact of the English National Health Service digital diabetes prevention programme: observational study	32
Superior weight loss with once-weekly semaglutide versus other glucagon-like peptide-1 receptor agonists is independent of gastrointestinal adverse events	31
KGF-2 and FGF-21 poloxamer 407 hydrogel coordinates inflammation and proliferation homeostasis to enhance wound repair of scalded skin in diabetic rats	31
Causal associations of insulin resistance with coronary artery disease and ischemic stroke: a Mendelian randomization analysis	31
Plasma lipidomics profile in pregnancy and gestational diabetes risk: a prospective study in a multiracial/ethnic cohort	31
Association between varying cut-points of intermediate hyperglycemia and risk of mortality, cardiovascular events and chronic kidney disease: a systematic review and meta-analysis	31
Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis	30
Decrease in Choroidal Vascularity Index of Haller’s layer in diabetic eyes precedes retinopathy	29
Metabolomics-based multidimensional network biomarkers for diabetic retinopathy identification in patients with type 2 diabetes mellitus	28
Physical behaviors and chronotype in people with type 2 diabetes	28
Effect of resistance training on HbA1c in adults with type 2 diabetes mellitus and the moderating effect of changes in muscular strength: a systematic review and meta-analysis	27
Adherence to ophthalmology referral, treatment and follow-up after diabetic retinopathy screening in the primary care setting	26
Long-term variability of glycemic markers and risk of all-cause mortality in type 2 diabetes: the Look AHEAD study	26
Adipokines in early and mid-pregnancy and subsequent risk of gestational diabetes: a longitudinal study in a multiracial cohort	26
Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes	25
SGLT2 inhibitors in patients with type 2 diabetes with non-alcoholic fatty liver diseases: an umbrella review of systematic reviews	25
Associations between grip strength and incident type 2 diabetes: findings from the UK Biobank prospective cohort study	25
Long-term lutein administration attenuates retinal inflammation and functional deficits in early diabetic retinopathy using the Ins2^Akita/+mice	24
Serum acylcarnitines and amino acids and risk of type 2 diabetes in a multiethnic Asian population	23
Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study	23
Effect of periodontal treatment on diabetes-related healthcare costs: a retrospective study	23
Effectiveness of at-home skin temperature monitoring in reducing the incidence of foot ulcer recurrence in people with diabetes: a multicenter randomized controlled trial (DIATEMP)	23
Renal hyperfiltration is independently associated with increased all-cause mortality in individuals with type 2 diabetes: a prospective cohort study	23
High probability of false-positive gestational diabetes mellitus diagnosis during early pregnancy	23
Glucagon-like peptide 1 agonists for treatment of patients with type 2 diabetes who fail metformin monotherapy: systematic review and meta-analysis of economic evaluation studies	23
Metabolic and energetic benefits of microRNA-22 inhibition	22
Predictors of 30-day unplanned hospital readmission among adult patients with diabetes mellitus: a systematic review with meta-analysis	22
Performance of the Eversense versus the Free Style Libre Flash glucose monitor during exercise and normal daily activities in subjects with type 1 diabetes mellitus	22
Correlation between markers of renal function and sight-threatening diabetic retinopathy in type 2 diabetes: a longitudinal study in an Indian clinic population	22
Incidence and pathophysiology of diabetes in South Asian adults living in India and Pakistan compared with US blacks and whites	22
Association of periodontal pocket area with type 2 diabetes and obesity: a cross-sectional study	21
Dietary intake of adults with and without diabetes: results from NHANES 2013–2016	21
Lifetime risk to progress from pre-diabetes to type 2 diabetes among women and men: comparison between American Diabetes Association and World Health Organization diagnostic criteria	21
Time in range–A1c hemoglobin relationship in continuous glucose monitoring of type 1 diabetes: a real-world study	21
Predicting the risk of future diabetic foot ulcer occurrence: a prospective cohort study of patients with diabetes in Tanzania	21
Impaired brain fractalkine-CX3CR1 signaling is implicated in cognitive dysfunction in diet-induced obese mice	21

miR-196b-5p-enriched extracellular vesicles from tubular epithelial cells mediated aldosterone-induced renal fibrosis in mice with diabetes	21
Lower extremity reamputation in people with diabetes: a systematic review and meta-analysis	21
Secular incidence trends and effect of population aging on mortality due to type 1 and type 2 diabetes mellitus in China from 1990 to 2019: findings from the Global Burden of Disease Study 2019	21
Islet inflammation is associated with pancreatic fatty infiltration and hyperglycemia in type 2 diabetes	21
One-year intensive lifestyle intervention and improvements in health-related quality of life and mental health in persons with type 2 diabetes: a secondary analysis of the U-TURN randomized controlled	20
Polyphenol-induced improvements in glucose metabolism are associated with bile acid signaling to intestinal farnesoid X receptor	20
Poorly controlled diabetes mellitus alters placental structure, efficiency, and plasticity	20
Lack of effect of Lactobacillus rhamnosus GG and Bifidobacterium lactis Bb12 on beta-cell function in children with newly diagnosed type 1 diabetes: a randomised controlled trial	19
Exercise training improves adipose tissue metabolism and vasculature regardless of baseline glucose tolerance and sex	19
Expression of the NEK7/NLRP3 inflammasome pathway in patients with diabetic lower extremity arterial disease	19
Clinical burden of diabetes in Italy in 2018: a look at a systemic disease from the ARNO Diabetes Observatory	19
Association between non-alcoholic fatty liver disease-associated hepatic fibrosis and bone mineral density in postmenopausal women with type 2 diabetes or impaired glucose regulation	19
Effect of diabetes on exosomal miRNA profile in patients with obesity	19
Democratizing type 1 diabetes specialty care in the primary care setting to reduce health disparities: project extension for community healthcare outcomes (ECHO) T1D	19
Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysis	19
Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus	19
Type 2 diabetes classification: a data-driven cluster study of the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) cohort	19
Social determinants of health impacting adherence to diabetic retinopathy examinations	19
Person-centered diabetes care and patient activation in people with type 2 diabetes	19
Real-world risk of hypoglycemia-related hospitalization in Japanese patients with type 2 diabetes using SGLT2 inhibitors: a nationwide cohort study	19
Additive effects of green tea and coffee on all-cause mortality in patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry	18
Role of ceramide-to-dihydroceramide ratios for insulin resistance and non-alcoholic fatty liver disease in humans	18
Glycolytic overload-driven dysfunction of periodontal ligament fibroblasts in high glucose concentration, corrected by glyoxalase 1 inducer	18
Better TIR, HbA1c, and less hypoglycemia in closed-loop insulin system in patients with type 1 diabetes: a meta-analysis	18
Drivers of weight loss in a CDC-recognized digital diabetes prevention program	18
Reliability of recommended non-invasive chairside screening tests for diabetes-related peripheral neuropathy: a systematic review with meta-analyses	17
Association of physical activity and sedentary behavior with type 2 diabetes and glycemic traits: a two-sample Mendelian randomization study	17
Non-invasive wearables for remote monitoring of HbA1c and glucose variability: proof of concept	17
Activation of Notch1 signaling in podocytes by glucose-derived AGEs contributes to proteinuria	17
Peripheral artery disease, lower limb revascularization, and amputation in diabetes patients with and without coronary artery disease: a cohort study from the Western Denmark Heart Registry	17
Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: a systematic review	17
Incidence and seasonality of type 1 diabetes: a population-based 3-year cohort study using the National Database in Japan	17
Real-world use of once-weekly semaglutide in patients with type 2 diabetes: pooled analysis of data from four SURE studies by baseline characteristic subgroups	17
Acute effects of the food preservative propionic acid on glucose metabolism in humans	17
Components of diabetes prevalence in Denmark 1996–2016 and future trends until 2030	17
Clinicopathological features of fast eGFR decliners among patients with diabetic nephropathy	17
Socioeconomic deprivation and development of diabetic retinopathy in patients with type 1 diabetes mellitus	17
Clinical and biochemical profile of 786 sequential episodes of diabetic ketoacidosis in adults with type 1 and type 2 diabetes mellitus	17
Incidence of diabetes and prediabetes and predictors of glycemic change among South Asians in the USA: the MASALA study	17
Development of a predictive risk model for all-cause mortality in patients with diabetes in Hong Kong	17
Association of vitamin B₁₂deficiency in people with type 2 diabetes on metformin and without metformin: a multicenter study, Karachi, Pakistan	17
Long-term efficacy and safety of oral semaglutide and the effect of switching from sitagliptin to oral semaglutide in patients with type 2 diabetes: a 52-week, randomized, open-label extension of the	17
Effects of D-allulose on glucose tolerance and insulin response to a standard oral sucrose load: results of a prospective, randomized, crossover study	17
Altered pain processing in patients with type 1 and 2 diabetes: systematic review and meta-analysis of pain detection thresholds and pain modulation mechanisms	17
Lifestyle interventions for type 2 diabetes management among migrants and ethnic minorities living in industrialized countries: a systematic review and meta-analyses	17
Preparedness cycle to address transitions in diabetes care during the COVID-19 pandemic and future outbreaks	16
Interleukin-6 mediated exercise-induced alleviation of adiposity and hepatic steatosis in mice	16
Contributions of amino acid, acylcarnitine and sphingolipid profiles to type 2 diabetes risk among South-Asian Surinamese and Dutch adults	16
Rebalancing glucolipid metabolism and gut microbiome dysbiosis by nitrate-dependent alleviation of high-fat diet-induced obesity	16
Long-term BMI change trajectories in Chinese adults and its association with the hazard of type 2 diabetes: evidence from a 20-year China Health and Nutrition Survey	16
Coagulopathy is a major extrapulmonary risk factor for mortality in hospitalized patients with COVID-19 with type 2 diabetes	16
Neurovascular coupling alterations in type 2 diabetes: a 5-year longitudinal MRI study	16
HbA1c during early pregnancy reflects beta-cell dysfunction in women developing GDM	16
Diabetic hand: prevalence and incidence of diabetic hand problems using data from 1.1 million inhabitants in southern Sweden	15
Metabolic recovery after weight loss surgery is reflected in serum microRNAs	15
Insulin pricing and other major diabetes-related concerns in the USA: a study of 46 407 tweets between 2017 and 2019	15
Plasma phenylalanine and tyrosine and their interactions with diabetic nephropathy for risk of diabetic retinopathy in type 2 diabetes	15
Cost-effectiveness of empagliflozin versus canagliflozin, dapagliflozin, or standard of care in patients with type 2 diabetes and established cardiovascular disease	15
Lipid accumulation product (LAP) as a potential index to predict risk of insulin resistance in young, non-obese Asian Indian males from Southern India: observations from hyperinsulinemic-euglycemic cl	15
Effects of a multifactorial ecosustainable isocaloric diet on liver fat in patients with type 2 diabetes: randomized clinical trial	15
Two-year use of flash glucose monitoring is associated with sustained improvement of glycemic control and quality of life (FLARE-NL-6)	15
Low mortality oxidative stress murine chronic wound model	15
Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry)	15
Use of a diabetes-specific nutritional shake to replace a daily breakfast and afternoon snack improves glycemic responses assessed by continuous glucose monitoring in people with type 2 diabetes: a ra	15
Hepatic fat is a stronger correlate of key clinical and molecular abnormalities than visceral and abdominal subcutaneous fat in youth	15
Mitochondrial DNA copy number and diabetes: the Atherosclerosis Risk in Communities (ARIC) study	15
Glycemic efficacy and safety of the SGLT2 inhibitor ertugliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease: an analysis from the VERTIS CV randomized trial	15
Long-term metformin adherence in the Diabetes Prevention Program Outcomes Study	14
Acute and chronic neuroinflammation is triggered by diabetic ketoacidosis in a rat model	14
Causes of diabetic ketoacidosis among adults with type 1 diabetes mellitus: insulin pump users and non-users	14
Differential DNA methylation profile in infants born small-for-gestational-age: association with markers of adiposity and insulin resistance from birth to age 24 months	14
Neighborhood walkability and pre-diabetes incidence in a multiethnic population	14
Plasma protein N-glycosylation is associated with cardiovascular disease, nephropathy, and retinopathy in type 2 diabetes	14
‘Never again will I be carefree’: a qualitative study of the impact of hypoglycemia on quality of life among adults with type 1 diabetes	14
Sleep characteristics and HbA1c in patients with type 2 diabetes on glucose-lowering medication	14
Lower resource utilization for patients with healed diabetic foot ulcers during participation in a prevention program with foot temperature monitoring	14
Rest-activity circadian rhythm and impaired glucose tolerance in adults: an analysis of NHANES 2011–2014	14
Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial	14
Incidence and determinants of hypophosphatemia in diabetic ketoacidosis: an observational study	14
Placental proteome abnormalities in women with gestational diabetes and large-for-gestational-age newborns	14

Time trends in the incidence of clinically diagnosed type 2 diabetes and pre-diabetes in the UK 2009–2018: a retrospective cohort study	14
Factors associated with adherence to using removable cast walker treatment among patients with diabetes-related foot ulcers	14
Use of oral diabetes medications and the risk of incident dementia in US veterans aged ≥60 years with type 2 diabetes	14
Cerebral small-vessel disease is associated with the severity of diabetic retinopathy in type 1 diabetes	14
Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes: findings from the Dutch Diabetes Pearl cohort	14
Corneal confocal microscopy compared with quantitative sensory testing and nerve conduction for diagnosing and stratifying the severity of diabetic peripheral neuropathy	13
Methylation status of vault RNA 2-1 promoter is a predictor of glycemic response to glucagon-like peptide-1 analog therapy in type 2 diabetes mellitus	13
Shape of the OGTT glucose response curve: relationship with β-cell function and differences by sex, race, and BMI in adults with early type 2 diabetes treated with metformin	13
Clinical decision support to improve management of diabetes and dysglycemia in the hospital: a path to optimizing practice and outcomes	13
Ethnic differences in beta cell function occur independently of insulin sensitivity and pancreatic fat in black and white men	13
Glycation by glyoxal leads to profound changes in the behavior of dermal fibroblasts	13
Trajectories in HbA1c and other risk factors among adults with type 1 diabetes by age at onset	13
Hemoglobin glycation index, calculated from a single fasting glucose value, as a prediction tool for severe hypoglycemia and major adverse cardiovascular events in DEVOTE	13
Plasma N-glycome shows continuous deterioration as the diagnosis of insulin resistance approaches	13
Children with type 1 diabetes have elevated high-sensitivity C-reactive protein compared with a control group	13
Methylation pattern of urinary DNA as a marker of kidney function decline in diabetes	13
Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC	13
Safety of medical compression stockings in patients with diabetes mellitus or peripheral arterial disease	13
Beta-cell failure rather than insulin resistance is the major cause of abnormal glucose tolerance in Africans: insight from the Africans in America study	13
Lack of association between either outpatient or inpatient glycemic control and COVID-19 illness severity or mortality in patients with diabetes	13
Management of type 2 diabetes in chronic kidney disease	13
Advanced glycation end products correlate with breast cancer metastasis by activating RAGE/TLR4 signaling	13
Impaired exocrine pancreatic function in different stages of type 1 diabetes	13
Lower estimated bone strength and impaired bone microarchitecture in children with type 1 diabetes	13
Risk of hypertension in middle-aged and elderly participants with newly diagnosed type 2 diabetes and prediabetes	12
Factors associated with missed appointments by adults with type 2 diabetes mellitus: a systematic review	12
Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuria	12
Occupational distribution of metabolic syndrome prevalence and incidence differs by sex and is not explained by age and health behavior: results from 75 000 Dutch workers from 40 occupational groups	12
A plasma metabolite score of three eicosanoids predicts incident type 2 diabetes: a prospective study in three independent cohorts	12
Prevalence of diabetes and pre-diabetes in Sri Lanka: a new global hotspot–estimates from the Sri Lanka Health and Ageing Survey 2018/2019	12
Associations between social network properties and metabolic syndrome and the mediating effect of physical activity: findings from the Cardiovascular and Metabolic Diseases Etiology Research Center (C	12
Recurrence rates suggest delayed identification of plantar ulceration for patients in diabetic foot remission	12
Association between brachial-ankle pulse wave velocity and risk of type 2 diabetes mellitus: results from a cohort study	12
Diabetes mellitus among adults with tuberculosis in the USA, 2010–2017	12
Clusters of people with type 2 diabetes in the general population: unsupervised machine learning approach using national surveys in Latin America and the Caribbean	12
Evaluation and management of COVID-19-related severity in people with type 2 diabetes	12
Prevalence, control, and treatment of diabetes, hypertension, and high cholesterol in the Amish	12
Anti-inflammatory, antioxidant and renoprotective effects of SOCS1 mimetic peptide in the BTBR ob/ob mouse model of type 2 diabetes	12
Long-term mortality among kidney transplant recipients with and without diabetes: a nationwide cohort study in the USA	12
Central administration of sodium-glucose cotransporter-2 inhibitors increases food intake involving adenosine monophosphate-activated protein kinase phosphorylation in the lateral hypothalamus in heal	12
Risk of 16 cancers across the full glycemic spectrum: a population-based cohort study using the UK Biobank	12
Changes in insulin sensitivity and insulin secretion during pregnancy and post partum in women with gestational diabetes	12
Associations between physical activity and trimethylamine N-oxide in those at risk of type 2 diabetes	12
Effect of alcohol consumption and the presence of fatty liver on the risk for incident type 2 diabetes: a population-based longitudinal study	12
Risk factors for new-onset diabetes mellitus after distal pancreatectomy	12
Systematic review and meta-analysis of mouse models of diabetes-associated ulcers	12
Klotho prevents epithelial–mesenchymal transition through Egr-1 downregulation in diabetic kidney disease	12